Can etanercept treatment failure in moderate-to-severe psoriasis be overcome by addition of low-dose methotrexate? A single-center experience
Author:
Affiliation:
1. Department of Dermatology, Rabin Medical Center–Beilinson Hospital, Petach Tikva, Israel;
2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Publisher
Informa UK Limited
Subject
Dermatology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09546634.2018.1441491
Reference21 articles.
1. Treatment of psoriasis with etanercept: the typical patient profile
2. Comparative efficacy of biological treatments for moderate-to-severe psoriasis: a network meta-analysis adjusting for cross-trial differences in reference arm response
3. Consensus Guidelines for the Management of Plaque Psoriasis
4. Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis
5. Biologic drug survival in Israeli psoriasis patients
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biologics combined with conventional systemic agents for the treatment of children with severe psoriasis. Real‐life data from the BiPe cohorts and a practice survey among French and Italian pediatric dermatologists;Dermatologic Therapy;2022-09-22
2. Combination Therapy with Biologic Agents;Updates in Clinical Dermatology;2022
3. A Six-Year Analysis of Biological Therapy for Severe Psoriasis in a Lithuanian Reference Centre of Dermatovenereology;Medicina;2020-06-04
4. IL-17A Inhibitor Switching – Efficacy of Ixekizumab Following Secukinumab Failure. A Single-center Experience;Acta Dermato Venereologica;2019
5. Oral Agents for Psoriasis;Updates in Clinical Dermatology;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3